Scarica l'app Stockscreener
329.35
2.03%
-6.84
Dopo l'orario di chiusura:
329.29
-0.06
-0.02%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ALNY Giù?
Forum
Previsione
Alnylam Pharmaceuticals Inc Borsa (ALNY) Ultime notizie
Here's How Much $100 Invested In Alnylam Pharmaceuticals 5 Years Ago Would Be Worth Today - Benzinga
Alnylam to Webcast Presentation at TD Cowen 46th Annual Health Care Conference - Business Wire
Understanding the Setup: (ALNY) and Scalable Risk - Stock Traders Daily
Fiera Capital Corp Grows Stake in Alnylam Pharmaceuticals, Inc. $ALNY - MarketBeat
NewEdge Wealth LLC Buys 7,091 Shares of Alnylam Pharmaceuticals, Inc. $ALNY - MarketBeat
ANTIPODES PARTNERS Ltd Cuts Stake in Alnylam Pharmaceuticals, Inc. $ALNY - MarketBeat
Will Alnylam Pharmaceuticals Inc. stock benefit from automationTrade Risk Summary & High Return Stock Watch Alerts - mfd.ru
China Universal Asset Management Co. Ltd. Cuts Stake in Alnylam Pharmaceuticals, Inc. $ALNY - MarketBeat
Alnylam Pharmaceuticals (ALNY) Reports $3B 2025 Revenue Driven by 151% TTR Franchise Surge - Insider Monkey
Assessing Alnylam Pharmaceuticals (ALNY) Valuation After First Profitable Year And Rapid Revenue Growth - simplywall.st
Analysts Offer Insights on Healthcare Companies: Alnylam Pharma (ALNY), Moderna (MRNA) and NewAmsterdam Pharma Company (NAMS) - The Globe and Mail
Shifting Trends in Biotechnology Mergers and Acquisitions - Intellectia AI
Regeneron Pharmaceuticals Inc. Lowers Position in Alnylam Pharmaceuticals, Inc. $ALNY - MarketBeat
Alnylam Pharmaceuticals (NASDAQ:ALNY) Stock Rating Upgraded by Freedom Capital - MarketBeat
Oligonucleotide Therapy Market to hit US$ 40.16 Billion by 2033 | - openPR.com
RNAi Therapeutics Market to hit US$ 8.80 Billion by 2033 | North - openPR.com
11,700 Shares in Alnylam Pharmaceuticals, Inc. $ALNY Bought by Alberta Investment Management Corp - MarketBeat
1 Reason I'd Buy Eli Lilly Stock and Never Sell - AOL.com
How Alnylam (NASDAQ:ALNY) Is Reframing Nasdaq Index Fund Allocation Trends - Kalkine Media
Analysts Trim Alnylam Pharmaceuticals, Inc. (ALNY) Targets but Keep Faith in 2026 Growth - Finviz
Alnylam Pharmaceuticals' (ALNY) "Buy" Rating Reaffirmed at HC Wainwright - MarketBeat
HC Wainwright Reiterates Buy Rating on ALNY with Price Target at $510 | ALNY Stock News - GuruFocus
Insider Unloading: Jeffrey V Poulton Sells $695K Worth Of Alnylam Pharmaceuticals Shares - Benzinga
EVP Of Alnylam Pharmaceuticals Makes $607K Sale - Benzinga
Sell Alert: Yvonne Greenstreet Cashes Out $2.16M In Alnylam Pharmaceuticals Stock - Benzinga
Inflation Data: Whats the beta of Alnylam Pharmaceuticals Inc stockM&A Rumor & Verified Short-Term Trading Plans - baoquankhu1.vn
Alnylam Pharmaceuticals, Inc. $ALNY Shares Purchased by Merit Financial Group LLC - Defense World
Eagle Health Investments LP Sells 22,400 Shares of Alnylam Pharmaceuticals, Inc. $ALNY - MarketBeat
Alnylam Pharmaceuticals, Inc. $ALNY Shares Sold by Skandinaviska Enskilda Banken AB publ - Defense World
Assessing Alnylam Pharmaceuticals (ALNY) Valuation As Mixed Share Price Returns Meet Bullish Fair Value Models - Yahoo Finance
Alnylam’s First Profitable Year Tests Durability Of TTR RNAi Franchise - simplywall.st
Alnylam Pharmaceuticals (NASDAQ:ALNY) Price Target Raised to $429.00 at Canaccord Genuity Group - Defense World
Why Alnylam Pharmaceuticals Stock Was Soaring on Monday - AOL.com
Alnylam EVP Garg sells $695k in stock to cover tax obligations - Investing.com
Jeffrey Poulton Sells 2,242 Shares of Alnylam Pharmaceuticals (NASDAQ:ALNY) Stock - MarketBeat
Alnylam Pharmaceuticals (NASDAQ:ALNY) EVP Tolga Tanguler Sells 1,959 Shares - MarketBeat
Yvonne Greenstreet Sells 6,958 Shares of Alnylam Pharmaceuticals (NASDAQ:ALNY) Stock - MarketBeat
Alnylam Pharmaceuticals (NASDAQ:ALNY) EVP Pushkal Garg Sells 2,242 Shares - MarketBeat
Alnylam shares jump as investors focus on profitability and upbeat 2026 revenue outlook - Quiver Quantitative
ALNY: Freedom Capital Markets Upgrades Rating Despite Lower Pric - GuruFocus
Alnylam: Strong Amvuttra Outperformance and High-Value Pipeline Optionality Support Buy Rating - TipRanks
ALNY: Canaccord Genuity Raises Price Target in Latest Analyst Up - GuruFocus
Canaccord Genuity Group Forecasts Strong Price Appreciation for Alnylam Pharmaceuticals (NASDAQ:ALNY) Stock - MarketBeat
Alnylam stock rating upgraded at Freedom Capital on AMVUTTRA growth By Investing.com - Investing.com UK
Vanguard Group Inc. Buys 268,313 Shares of Alnylam Pharmaceuticals, Inc. $ALNY - MarketBeat
Principal Financial Group Inc. Sells 45,114 Shares of Alnylam Pharmaceuticals, Inc. $ALNY - MarketBeat
ABN Amro Investment Solutions Has $597,000 Stake in Alnylam Pharmaceuticals, Inc. $ALNY - MarketBeat
Alnylam targets 25% revenue CAGR through 2030 amid AMVUTTRA launch momentum and pipeline expansion - MSN
Alnylam Pharmaceuticals (ALNY) Investor Outlook: Analyzing The 46% Potential Upside - DirectorsTalk Interviews
Shell Asset Management Co. Sells 4,478 Shares of Alnylam Pharmaceuticals, Inc. $ALNY - MarketBeat
Aberdeen Group plc Sells 61,228 Shares of Alnylam Pharmaceuticals, Inc. $ALNY - MarketBeat
Will First GAAP Profit Year and Amvuttra Expansion Shift Alnylam Pharmaceuticals' (ALNY) Narrative? - simplywall.st
Cardiovascular Biologics Market to Reach US$ 4.23 Billion - openPR.com
12,116 Shares in Alnylam Pharmaceuticals, Inc. $ALNY Purchased by Cibc World Market Inc. - MarketBeat
Alnylam Pharmaceuticals (ALNY) Turns Profitable With Q4 EPS Of US$1.41 Challenging Bearish Narratives - simplywall.st
What are analysts’ price targets for Alnylam Pharmaceuticals Inc.Quarterly Performance Summary & Free Expert Verified Stock Movement Alerts - mfd.ru
Should You Buy Alnylam Pharmaceuticals Before Feb. 12? - AOL.com
Is Alnylam Pharmaceuticals (ALNY) one of the best upside stocks to invest in right now? - MSN
Alnylam Pharmaceuticals (NASDAQ:ALNY) Lowered to "Buy" Rating by Wall Street Zen - MarketBeat
Is Alnylam Pharmaceuticals (ALNY) One of the Best Upside Stocks to Invest In Right Now? - Insider Monkey
Alnylam Pharmaceuticals Q4 Earnings Call Highlights - Defense World
Is It Time To Revisit Alnylam Pharmaceuticals (ALNY) After The Recent Share Price Pullback? - simplywall.st
Alnylam Hit Hard As Investors Forced To Revise Future Profit Expectations (ALNY) - Seeking Alpha
RBC Capital lowers Alnylam Pharmaceuticals stock price target on short-term headwinds - Investing.com Canada
ALNY Q4 Earnings Beat, Sales Miss Despite Y/Y Growth, Stock Down - Bitget
2.35%
2.15%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):